ISRCTN58767633已完成未知
The clinical study of peripheral subcutaneous neuromodulation in postherpetic neuralgia treatment
Shanghai Sixth People?s Hospital (China)0 个研究点目标入组 102 人开始时间: 2007年10月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
2013 results in https://pubmed.ncbi.nlm.nih.gov/24165049/ (added 10/06/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients were between 60 and 90 years old
- •2. Patients must have pain present for more than 6 months after the healing of shingles skin rash
- •3. Patients at screening must have a score of greater than or equal to 40 mm on the pain visual analogue scale
排除标准
- •1. Patients withdrawn from the study
- •2. Patients can't take self-assessment of the pain due to PHN
研究者
相似试验
已完成
不适用
A clinical trial to develop new ways of measuring nerve healing after injuryPeripheral nerve injuryInjury, Occupational Diseases, PoisoningInjury of nerve(s) of unspecified body regionISRCTN17886637The University of Manchester5
已完成
不适用
Subcutaneous Peripheral Nerve Stimulation (PNS) as "Hybrid Stimulation" After Failure of Spinal Cord Stimulation (SCS) to Control the Back Pain Component in Failed Back Surgery Syndrome (FBSS) Patients.(CUMPNS Study)Failed Back Surgery SyndromeNCT02110888Poitiers University Hospital14
已完成
3 期
Treatment of Peripheral Neuropathy in Patients With DiabetesDiabetic NeuropathiesDiabetes MellitusNCT00044421Eli Lilly and Company400
未知
3 期
Study to assess the efficacy, safety and tolerability of secukinumab in Japanese subjects with GPPGeneralized Pustular Psoriasis (GPP)JPRN-jRCT2080222256ovartis Pharma K.K.
已完成
1 期
Clinical study with subsequent subcutaneous administration of GEN0101 in the patients enrolled in the Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 (GEN0101-JM003).JPRN-UMIN000026892Osaka University Hospital, Center for respiratory6